About
A man with no sperm in his ejaculate may have a deletion on the long arm of the Y chromosome — in the AZF regions, where the genes that drive sperm production sit. That deletion is not a treatable cause; it is a heritable one, and a male child conceived by ICSI from that man inherits it and will face the same diagnosis. The test that finds it is a molecular assay, and Zhadyra Shagyrova’s named skill set includes it, along with CFTR analysis for cystic fibrosis carrier status and sperm DNA fragmentation testing.
She trained as a biotechnologist, taking her BSc at the Faculty of Biology of al-Farabi Kazakh National University in Almaty in 2011 and a master’s degree there in 2013. That is a different undergraduate preparation from a general biology degree: molecular technique, assay design and genetic analysis are the core of a biotechnology curriculum, and it shows in what she is listed as doing. She has worked in ART laboratories for more than thirteen years, longer than either of the clinic’s other two embryologists, and has five publications to her name alongside conference contributions.
Her continuing certification follows the same two threads — bench technique and preservation. In 2018 she completed a master class on the preservation of female and male fertility and took a certificate from the Kazakh Association of Reproductive Medicine, attending the tenth international congress on assisted reproductive technologies. In 2022 she gained conference certificates from the 28th congress of the Russian Association of Human Reproduction and from the ESHRE meeting in Milan, and she has also attended IVIRMA congresses, the Spanish network whose clinical standards the Georgian clinics partly trace.
Clinical Expertise
- Sperm DNA fragmentation testing: Measurement of damage in the sperm’s genetic material, which standard semen parameters do not detect and which is associated with poor embryo development and repeated failure.
- Y-chromosome AZF microdeletion analysis: Molecular testing in men with severe oligozoospermia or azoospermia, both a diagnosis and an inheritance question.
- CFTR cystic fibrosis gene analysis: Carrier testing relevant where congenital absence of the vas deferens is found, since CBAVD is frequently a CFTR presentation rather than a surgical one.
- ICSI and PICSI: Injection fertilization, including hyaluronan-based selection.
- Embryo biopsy: Trophectoderm sampling at blastocyst stage for preimplantation genetic testing.
- Cryopreservation of oocytes, embryos and semen: Freezing and thawing across all three material types, the technical core of a preservation program.
- Semen analysis with morphology and MAR testing: Baseline andrology assessment including antisperm antibody detection.
- IVF laboratory support: Culture, grading and transfer-stage work within the clinic’s cycle program.
Why Choose Zhadyra Shagyrova
She does the genetic assays, not only the micromanipulation. Most embryologists are listed for injection and freezing. Her named scope includes AZF microdeletion, CFTR and DNA fragmentation testing — the molecular results that change whether a couple should use their own sperm, donate, or be counselled about what a son would inherit.
Biotechnology training underneath. An undergraduate degree in biotechnology rather than general biology is the preparation that makes running those assays a normal task instead of an outsourced one.
Thirteen years at the bench. Her tenure exceeds both colleagues in the same laboratory, which in embryology is the period over which a scientist accumulates the failures that teach technique.
Fertility preservation is a documented special interest. Her 2018 master class was specifically on preserving female and male fertility, and her cryopreservation work covers eggs, embryos and sperm — the right combination for a patient facing cancer treatment.
She publishes. Five papers, plus certificates from the Russian Association of Human Reproduction, ESHRE Milan and IVIRMA congresses. A laboratory scientist who writes up cases is one whose methods get examined.
Professional Affiliations
BSc in Biotechnology (2011) and MSc (2013), al-Farabi Kazakh National University, Almaty. Certificate from the Kazakh Association of Reproductive Medicine following a 2018 master class on preservation of female and male fertility, and attendance at the 10th international congress on assisted reproductive technologies. 2022 conference certificates from the 28th congress of the Russian Association of Human Reproduction and the ESHRE congress in Milan; IVIRMA congress attendance. Author of five publications.
Suitable For
- Men with severe low sperm count or azoospermia, whose cause needs a genetic answer before a cycle is planned.
- Couples where a congenital absence of the vas deferens has been found, for whom CFTR testing carries implications beyond fertility.
- Anyone told previous embryos developed poorly without explanation, where sperm DNA damage is a candidate cause that routine analysis misses.
- Patients banking eggs, sperm or embryos before gonadotoxic treatment, matching her documented preservation focus.
- Couples requiring PGT with an inherited single-gene risk, where biopsy and the genetic question have to be sequenced correctly.